Vulnerability in I-Sens Smartlog Diabetes Management Software
CVE-2017-13993
An Uncontrolled Search Path or Element issue was discovered in i-SENS SmartLog Diabetes Management Software, Version 2.4.0 and prior versions. An uncontrolled search path element vulnerability has been identified which could be exploited by placing a specially crafted DLL file in the search path. If the malicious DLL is loaded prior to the valid DLL, an attacker could execute arbitrary code on the system. This vulnerability does not affect the connected blood glucose monitor and would not impact delivery of therapy to the patient.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.8 (High). Vector: CVSS:3.0/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.018 (77.1th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 77th percentile — 77.1% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.018 · newest: 0.018 · change: 0.000
Affected products
- I-Sens Smartlog Diabetes Management Software
- I-Sens, Inc. Smartlog Diabetes Management Software — versions i-SENS, Inc. SmartLog Diabetes Management Software
Weakness classification (CWE)
References
- ics-cert.us-cert.gov/advisories/ICSMA-17-250-01 (US Government Resource, Patch, Third Party Advisory)
- www.securityfocus.com/bid/100659 (VDB Entry, Third Party Advisory, vdb-entry)
Frequently asked questions
- What is CVE-2017-13993?
- CVE-2017-13993 is a high-severity vulnerability in I-Sens Smartlog Diabetes Management Software, classified under Unquoted Search Path or Element. CVSS score: 7.8/10. Published 2017-10-05.
- How severe is CVE-2017-13993?
- High severity. CVSS v3 base score is 7.8 out of 10.